LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Global Microbiology Diagnostic Devices and Equipment Market Driven by Emergence of Novel Pathogens

By LabMedica International staff writers
Posted on 20 Feb 2023
Print article
Image: The global microbiology diagnostic devices and equipment market is expected to reach close to USD 6 billion in 2026 (Photo courtesy of Pexels)
Image: The global microbiology diagnostic devices and equipment market is expected to reach close to USD 6 billion in 2026 (Photo courtesy of Pexels)

The global microbiology diagnostic devices and equipment market is expected to register a compound annual growth rate (CAGR) of 10.7% from USD 3.42 billion in 2021 to USD 5.69 billion in 2026 and grow further at a CAGR of 8.6% from 2026 to reach USD 8.56 billion in 2031. The market growth has been driven by increased healthcare expenditure, growth in the emerging markets, rapid technological advances, fast-paced increase in the aging population and the emergence of novel pathogenic infestations. However, regulatory challenges, political uncertainties, reduction in free trade and low healthcare reimbursements have negatively impacted market growth. Going forward, a rise in funding, growth in the aging population, enhanced healthcare access, and increase in various bacterial and viral epidemics will drive the growth of the global microbiology diagnostic devices and equipment market. However, the market growth could be hindered by a lack of skilled/trained microbiologists and insufficient and outdated health systems.

These are the latest findings of ResearchAndMarkets.com (Dublin, Ireland), a leading source for international market research reports and market data.

Based on type, the reagents and consumables market segment dominated the microbiology diagnostic devices and equipment market with the largest share of 80.6% in 2021 and is expected to register the fastest CAGR of 11.7% during the 2021-2026 forecast period. Based on type, the bacterial colony counters segment dominated the laboratory instruments market with the largest share of 24.8% in 2021 and is expected to register the fastest CAGR of 6.2% during the forecast period. Based on type, the microscopes segment dominated the microbiology analyzers market with the largest share of 56.1% in 2021 and is expected to register the fastest CAGR of 8.2% during the forecast period.

Based on type, the general reagents segment dominated the reagents and consumables market with the largest share of 60.5% in 2021. However, going forward, the pathogen-specific kits segment is expected to register the fastest CAGR of 14.6% during the forecast period. By end-user, the diagnostic laboratories segment dominated the microbiology diagnostic devices and equipment market with the largest share of 56.8% in 2021. However, going forward, the other end-users segment is expected to register the fastest CAGR of 10.9% during the forecast period.

Geographically, North America dominated the global microbiology diagnostic devices and equipment market with the largest share of 34.5% in 2021, followed by Asia Pacific and other regions. However, going forward, the microbiology diagnostic devices and equipment market in Africa and South America is expected to register the fastest CAGRs of 14.5% and 14.3%, respectively during the forecast period, followed by Eastern Europe and Middle East with CAGRs of 13.3% and 12.9%, respectively.

Related Links:
ResearchAndMarkets.com

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Auto Clinical Chemistry Analyzer
cobas c 703
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Sekisui Diagnostics UK Ltd.